SI-BONE, INC. Cash and Restricted Cash
SI-BONE, INC. (SIBN) had Cash and Restricted Cash of $33.13 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.13M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.53M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42.24M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.49M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $33.13M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $33.53M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $42.24M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $26.49M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $34.15M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $41.19M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $34.95M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $30.23M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $25.58M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $32.04M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $33.27M 10-K · filed 2026-02-24 |
| 2023-09-30 | $53.49M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $110.81M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $22.97M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $20.72M 10-K · filed 2026-02-24 |
| 2022-09-30 | $26.30M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $24.32M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $27.33M 10-Q · filed 2023-05-02 |
| 2021-12-31 | $63.42M 10-K · filed 2025-02-25 |
| 2021-09-30 | $59.86M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $48.13M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $37.36M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $53.58M 10-K · filed 2023-03-02 |
| 2020-09-30 | $56.00M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $66.17M 10-Q · filed 2021-08-04 |
| 2020-03-31 | $67.57M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $10.44M 10-K · filed 2022-03-01 |
| 2019-09-30 | $12.61M 10-Q · filed 2020-11-03 |
| 2019-06-30 | $11.50M 10-Q · filed 2020-08-04 |
| 2019-03-31 | $12.56M 10-Q · filed 2020-05-05 |
| 2018-12-31 | $25.12M 10-K · filed 2021-03-10 |
| 2018-09-30 | $14.00M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $16.23M 10-Q · filed 2019-08-07 |
| 2018-03-31 | $17.79M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $22.41M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |